ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.
The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.
read more
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
385 days ago
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
RTTNews
|
452 days ago
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
712 days ago
UK Manufacturing Sector Returns To Growth
The UK manufacturing sector returned to growth in May as production grew the most in more than two years on improved order intakes, final survey data released by S&P Global revealed on Monday. The manufacturing Purchasing Managers' Index advanced to 51.2 in May from 49.1 in April. This was the highest reading since July 2022 but a tick below the initial estimate of 51.3.
RTTNews
|
4h 8min ago
Liquidia Says Court Denies United Therapeutics' Motion For Injunction To Block Launch Of YUTREPIA
Liquidia Corp. (LQDA) announced Monday that Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the motion for preliminary injunction filed by United Therapeutics (UTHR) on Friday that sought to block the launch of Liquidia's YUTREPIA (treprostinil) inhalation powder to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD).
RTTNews
|
4h 50min ago
Eurozone Manufacturing Activity Posts Slower Contraction
Downturn in the euro area manufacturing activity softened in May as production moved closer to stabilization and orders fell at a slower pace amid the rising business sentiment, final HCOB survey results from S&P Global showed on Monday. The manufacturing Purchasing Managers' Index rose to 47.3 in May from 45.7 in April. The flash estimate was 47.4.
RTTNews
|
5h 5min ago
Bay Street Likely To Open Slightly Higher
The Canadian market may open with a positive bias Monday morning, but the upside is likely to be limited as investors await the Bank of Canada's interest rate decision this week.
RTTNews
|
5h 14min ago
Honeywell Closes Acquisition Of Carrier's Global Access Solutions Unit; Boosts FY24 Profit Outlook
Honeywell International Inc. (HON) announced Monday the completion of its acquisition of Carrier Global Corp.'s (CARR) Global Access Solutions business for $4.95 billion.
RTTNews
|
5h 39min ago
